JS

Jeena Sikho Lifecare Ltd

Q1 FY26Leisure Services

Jeena Sikho Lifecare Q1 FY26 earnings call: Revenue & Margins

Q1 FY26 earnings call: what management guided on revenue, margins and order book.

Price₹505
Market cap₹7.2K Cr
P/E32.4
Updated23 Aug 2026
Read4 min read

The short version

Target turnover of INR 700 crores for the year, maintaining 20%-25% PAT margin (Page 20). Revenue grew 74% YoY to INR 174 crores in Q1 FY '26; similar growth expected as OTC product launches scale.

From Jeena Sikho Lifecare Ltd's Q1 FY26 earnings-call transcript · updated 23 Aug 2026.

Revenue & Sales Performance

  • Target turnover of INR 700 crores for the year, maintaining 20%-25% PAT margin (Page 20).
  • OTC (over-the-counter) product launch on July 22, 2025, expected to add incremental revenue; turnover target of INR 500 crores from OTC in 1.5 to 2 years (Pages 17, 12).
  • Plans to launch 6-7 new products before March 31, 2026, and 15-20 products in the next year, aiming for INR 500 crores turnover from products in 1.5 to 2 years with 20% PAT margin (Page 20).
  • Volume growth seen in medicines; Q1 2025 saw 125,000 people taking medicines, annualized to potentially 500,000 (Page 30).

2 more points management made on revenue & sales performance

Profitability & Margins

See what Jeena Sikho Lifecare Ltd said on profitability & margins — free account, 30 seconds.

Capital Expenditure Plans

  • The company plans to add 1,000 beds per year as part of its long-term growth, targeting 7,000 to 10,000 beds in 3 to 5 years.
  • Considering the acquisition of a large hospital with 1,000 beds is under discussion.
  • Focus on opening clinic franchises, hospitals, and daycare franchises across regions (south, east, west, north) to expand reach.
  • New product launches are planned: 6-7 products before March 31, 2026, and 15-20 products next year aiming for INR 500 crore turnover from product sales within 1.5 to 2 years.
  • Investment in in-house ERP and software development for improved operational efficiency.

2 more points management made on capital expenditure plans

Top-ranked in Leisure Services

Ranked on what management guided this quarter

5x potential
Rev 2Mar 1
2Jubilant Food.
Rev 2Mar 3
3
Rev 2Mar 3
4
Rev 2Mar 3
5
Rev 2Mar 3
Sign up free to see 3 moreTakes 30 seconds · no cardSign up

Rank buckets describe management commentary on revenue and margin. Not investment advice, and not a forecast of returns.

Fundraising & Capital Structure

See what Jeena Sikho Lifecare Ltd said on fundraising & capital structure — free account, 30 seconds.

Order Book & Pipeline

The transcript does not explicitly mention the current or expected order book or pending orders for Jeena Sikho Lifecare Limited. However, relevant details indicating growth and demand include: - In Q1 FY 2025-26, 1,25,000 people took medicines; extrapolated to an estimated 5,00,000 annually if the run rate maintains. - OTC product launch on 22nd July with strong initial demand: 21 orders in the first hour, quick stock depletion in 4 days. - Plans to expand OTC turnover to INR 500 crores in 1.5 to 2 years. - Medicine sales grew from INR 63 crores in Q4 to INR 80 crores in Q1. - Hospital beds expanding rapidly with 2,570 operational beds, targeting 2,850 by March 2026.

2 more points management made on order book & pipeline

Jeena Sikho Lifecare Ltd — Quarterly revenue & net profit

Revenue Net profit
Sep 2024
Dec 2024
Mar 2025
Jun 2025
Sep 2025
Dec 2025

Reported quarterly figures (₹ Cr). Latest: revenue ₹222 Cr, net profit ₹67 Cr. Revenue and profit are scaled separately — hover a quarter for exact figures.

Full financials →

Others in Leisure Services this season

  • ITC Hotels Ltd (Q1 FY26)

    Standalone Revenue from Operations for Q1 FY26: ₹744 crore, up 14% YoY; Total Revenue: ₹783 crore, up 20% YoY (Page 36) . Key concall takeaways from ITC Hotels…

  • EIH Associated Hotels Ltd (Q1 FY26)

    Revenue from Operations for Q1 FY26: Rs 68.7 Crores, up from Rs 64.5 Crores in Q1 FY25 (year-on-year growth of ~6.5%). Key concall takeaways from EIH…

  • Easy Trip Planners Ltd (Q1 FY26)

    Q1 FY26 Gross Booking Revenue (GBR): INR 2,065.8 crore, reflecting a 151.0% year-on-year increase in Dubai operations and strong growth overall (page 5, 7…

  • Praveg Ltd (Q1 FY26)

    Q1 FY26 consolidated total income: ₹39.86 Cr, up 61.50% from Q1 FY25 ₹24.68 Cr (Page 5, 6, 7). Key concall takeaways from Praveg Ltd's Q1 FY26 earnings call…

🔎 Who's planning the most growth?

Companies ranked by management's own guidance — revenue, margins, capex and order book, from every earnings call in India.

See rankings →

Frequently Asked Questions

What were Jeena Sikho Lifecare Ltd Q1 FY26 results?

Target turnover of INR 700 crores for the year, maintaining 20%-25% PAT margin (Page 20). Revenue grew 74% YoY to INR 174 crores in Q1 FY '26; similar growth expected as OTC product launches scale.

What is Jeena Sikho Lifecare Ltd share price analysis?

Jeena Sikho Lifecare Ltd currently shows a neutral. The stock trades at a P/E of 32.4 with a market cap of ₹7,200 Cr. Investors should review the full earnings analysis for detailed insights.

Is Jeena Sikho Lifecare Ltd planning capital expenditure?

The company plans to add 1,000 beds per year as part of its long-term growth, targeting 7,000 to 10,000 beds in 3 to 5 years.

Keep Jeena Sikho Lifecare Ltd on your radar — track it to get its next earnings analysis in your feed.

This analysis is AI-generated based on publicly available earnings data and the company's earnings call transcript. This is not investment advice. Please consult a SEBI-registered advisor before making investment decisions.